SCHEMBL31677181

SCHEMBL31677181

CCCCOC(=O)N1CCC(O)(COCCC2CCN(C(=O)OCc3ccccc3)CC2)CC1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 2/20 0.52
SMN1; SMN2 Q16637 3/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
CYP2C19 P33261 1/20 0.47
FAAH O00519 1/20 0.47
CCR5 P51681 2/20 0.46
GRIN2B Q13224 9/20 0.46
HTT P42858 1/20 0.46
OPRD1 P41143 1/20 0.45
OPRK1 P41145 1/20 0.45
CYP2D6 P10635 4/20 0.45
CYP2C9 P11712 4/20 0.45
KDM1A O60341 1/20 0.43
CYP3A4 P08684 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29201718 0.88 CHRM4 (0.50) CHRM4SMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL28978044 0.85 SMN1; SMN2 (0.54) CHRM4SMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL13597265 0.81 SMN1; SMN2 (0.64) CHRM4SMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL28978001 0.80 SMN1; SMN2 (0.45) CHRM4SMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL13519706 0.79 SMN1; SMN2 (0.67) CHRM4SMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL7299227 0.79 L3MBTL1 (0.59) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL23783162 0.79 SMN1; SMN2 (0.52) CHRM4SMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL31303443 0.78 SMN1; SMN2 (0.46) CHRM4SMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL6983413 0.77 L3MBTL1 (0.62) SMN1; SMN2RAB9ACYP2C19FAAHCYP2C9
SCHEMBL31303381 0.77 SMN1; SMN2 (0.45) CHRM4SMN1; SMN2NPC1RAB9ACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4606803-A1 KRAS G12D DEGRADATION AGENT, AND PREPARATION METHOD AND USE THEREFOR Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. (CN) 2025-08-27 EP disclosed